AKT1 and breast carcinoma: Recently, increasing evidence suggests that the activation of AKT has a key role in the function of CSLCs and modulates the percent of SP cells in a variety of cancers, including esophageal carcinoma [13], glioma tumors [14], lung cancer [15] and breast cancer [16].